3-Hydroxy Lidocaine D5
| Product Name | 3-Hydroxy Lidocaine D5 |
|---|---|
| Alternate Names | Lidocaine Stable Isotopes, Stable Isotopes of Lidocaine |
| CAT No. | CS-T-56116 |
| CAS No. | 1286482-71-0 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | Not Available |
| Mol. For. | Not Available |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Lidocaine |
| Canonical Smiles | CCNC(C(=O)NC1=C(C=CC(=C1C)O)C)NCC |
| InchIKey | RDAJRAZHLYTMHR-VGGRJZMQSA-N |
| Inchl | InChI=1S/C14H23N3O2/c1-5-15-13(16-6-2)14(19)17-12-9(3)7-8-11(18)10(12)4/h7-8,13,15-16,18H,5-6H2,1-4H3,(H,17,19)/i1D2,5D2/hD |
| IUPAC | 2-[deuterio(1,1,2,2-tetradeuterioethyl)amino]-2-(ethylamino)-N-(3-hydroxy-2,6-dimethylphenyl)acetamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
3-Hydroxy Lidocaine D5 is a modified form of Lidocaine, which is a common local anesthetic used in the medical field. The addition of deuterium to the molecule provides greater stability to the compound and allows for more precise analysis in research studies.
This particular form of Lidocaine is primarily used in research studies to better understand the pharmacokinetics and metabolism of Lidocaine in the body. It is also used as a reference standard in analytical chemistry and forensic toxicology.
Chemically, 3-Hydroxy Lidocaine D5 has the molecular formula C14H22D5N2O2 and a molecular weight of 261.4 g/mol. It is a white crystalline powder that is soluble in water and ethanol.
When administered, 3-Hydroxy Lidocaine D5 is metabolized by the liver into its active form, Lidocaine. This process involves the hydrolysis of the ester bond and the removal of the deuterium atoms. The metabolites are then excreted in the urine.
While 3-Hydroxy Lidocaine D5 has limited clinical applications, its use in research studies has provided valuable insights into the pharmacokinetics and metabolism of Lidocaine, which can ultimately lead to improved patient outcomes and safety in clinical practice.
Get an Instant Quote
Related Compounds
N-Nitroso Lidocaine EP Impurity E-15N 13C2 | Lidocaine D10 Hydrochloride | N-Nitroso Lidocaine EP Impurity E D4 | Nor Lidocaine-d5 Hydrochloride | Lidocaine-D6 |